Market Overview

Benzinga's Top #PreMarket Losers

Share:
Related GILD
Gilead Looking To Buy Incyte? It Makes Sense
Wall Street's M&A Chatter From March 10-12
Marketplace Roundtable: Biotech Hanging In The Balance (Seeking Alpha)
Related VRTX
Leerink Presents: Your 2017 Biopharma Catalyst Tracker
Benzinga's Top Upgrades, Downgrades For March 17, 2017
Marketplace Roundtable: Biotech Hanging In The Balance (Seeking Alpha)

Gilead Sciences Inc. (NASDAQ: GILD) shares dropped 9.73% to $97.90 in pre-market trading. Gilead Sciences and Ono Pharma reported that the companies have entered into an exclusive license agreement for the development and commercialization of ONO-4059.

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) shares fell 3.14% to $115.17 in pre-market trading after gaining 0.99% on Friday.

Energy XXI Ltd. (NASDAQ: EXXI) shares declined 2.92% to $3.33 in pre-market trading after jumping 11.00% on Friday.

Randgold Resources Limited (NASDAQ: GOLD) fell 1.22% to $66.70 in pre-market trading after dropping 1.32% on Friday.

Biogen Idec Inc. (NASDAQ: BIIB) shares dropped 1.57% to $354.99 after gaining 1.97% on Friday.

Posted-In: PreMarket LosersNews Movers & Shakers Pre-Market Outlook Markets

 

Related Articles (BIIB + EXXI)

View Comments and Join the Discussion!